KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $2.5 million.

  • Pacific Biosciences Of California's Depreciation & Amortization (CF) fell 4130.69% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year decrease of 592.33%. This contributed to the annual value of $13.8 million for FY2024, which is 2000.0% up from last year.
  • Latest data reveals that Pacific Biosciences Of California reported Depreciation & Amortization (CF) of $2.5 million as of Q3 2025, which was down 4130.69% from $2.7 million recorded in Q2 2025.
  • Pacific Biosciences Of California's 5-year Depreciation & Amortization (CF) high stood at $5.1 million for Q1 2025, and its period low was $1.6 million during Q2 2021.
  • For the 5-year period, Pacific Biosciences Of California's Depreciation & Amortization (CF) averaged around $2.8 million, with its median value being $2.7 million (2025).
  • Examining YoY changes over the last 5 years, Pacific Biosciences Of California's Depreciation & Amortization (CF) showed a top increase of 5836.42% in 2025 and a maximum decrease of 4130.69% in 2025.
  • Over the past 5 years, Pacific Biosciences Of California's Depreciation & Amortization (CF) (Quarter) stood at $2.3 million in 2021, then increased by 13.56% to $2.6 million in 2022, then rose by 17.56% to $3.0 million in 2023, then decreased by 4.81% to $2.9 million in 2024, then decreased by 14.19% to $2.5 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $2.5 million for Q3 2025, versus $2.7 million for Q2 2025 and $5.1 million for Q1 2025.